Accession Number:

AD1049458

Title:

Enhancing Immune Checkpoint Inhibitor Therapy in Kidney Cancer

Descriptive Note:

Technical Report,30 Sep 2016,29 Sep 2017

Corporate Author:

University of Texas Southwestern Medical Center Dallas United States

Personal Author(s):

Report Date:

2017-10-01

Pagination or Media Count:

5.0

Abstract:

The purpose of this work is to develop strategies to enhance immune checkpoint inhibition in kidney cancer. The work is designed to test different strategies to induce or enhance the abscopal in a kidney cancer model by combining ablative techniques or TLR agonists with PD1 inhibitors. Funds were transferred to UT Southwestern mid 2017. The PI is in the process of getting IACUCACURO approval for the proposed animal studies.

Subject Categories:

  • Medicine and Medical Research
  • Pharmacology
  • Biochemistry

Distribution Statement:

APPROVED FOR PUBLIC RELEASE